Trials / Completed
CompletedNCT05461352
Long-Term Study of TS-142 in Patients with Insomnia
A Multi-center, Open-label Long-Term Study of TS-142 in Patients with Insomnia Disorder
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 401 (actual)
- Sponsor
- Taisho Pharmaceutical Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a randomized, open-label, multi-center long-term study in patients with insomnia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | TS-142 5 mg | Participants received repeated doses of 5 mg of TS-142 (oral tablet) |
| DRUG | TS-142 10 mg | Participants received repeated doses of 10 mg of TS-142 (oral tablet) |
Timeline
- Start date
- 2022-10-11
- Primary completion
- 2024-03-07
- Completion
- 2024-03-07
- First posted
- 2022-07-18
- Last updated
- 2025-02-28
Locations
1 site across 1 country: Japan
Source: ClinicalTrials.gov record NCT05461352. Inclusion in this directory is not an endorsement.